Abnormal activation of the EGFR signaling pathway mediates the downregulation of miR-145 through the ERK1/2 in non-small cell lung cancer

Yuehui Guo(Shanghai Third People's Hospital), Feng‐Hou Gao(Shanghai Ninth People's Hospital)
Oncology Reports
February 11, 2014
Cited by 27


Related Papers